eLetters

151 e-Letters

published between 2009 and 2012

  • Cost effectiveness of transcatheter aortic valves
    Andrea Messori

    One issue that has not been discussed in the paper by Christofferson et al. [1] is the cost-effectiveness of transcatheter therapies, particularly those based on the new transcatheter aortic valves.

    Previous cost-effectiveness studies on surgical aortic valve replacement (AVR) compared AVR versus best medical therapy (or no operation) and found that AVR had an acceptable cost-effectiveness profile (cost per qua...

    Show More

Pages